"Clinically advanced, evidence-based cancer care."

During the past decade, Charles R. Wood Cancer Center at Glens Falls Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles R. Wood Cancer Center at Glens Falls Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 21 trials, followed by "NSABP Foundation Inc" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored and "Eastern Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles R. Wood Cancer Center at Glens Falls Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Charles R. Wood Cancer Center at Glens Falls Hospital" are "Breast Cancer" (12 trials), "Lung Cancer" (6 trials), "Lymphoma" (4 trials), "Melanoma (Skin)" (3 trials) and "Acute Leukemia" (2 trials). Many other conditions were trialed in "Charles R. Wood Cancer Center at Glens Falls Hospital" in a lesser frequency.

Most popular intervention types in "Charles R. Wood Cancer Center at Glens Falls Hospital" are "Drug" (29 trials), "Biological" (15 trials), "Other" (9 trials), "Radiation" (8 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "bevacizumab" (5 trials), "carboplatin" (5 trials), "cisplatin" (5 trials) and "cetuximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Charles R. Wood Cancer Center at Glens Falls Hospital" are 29 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Charles R. Wood Cancer Center at Glens Falls Hospital". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Charles R. Wood Cancer Center at Glens Falls Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charles R. Wood Cancer Center at Glens Falls Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".